The Ten Leading Indian Pharmaceutical Companies Generated Over $15bn Across May 2014 to April 2015
GMR Data’s new pharmaceutical market report "The Indian Pharmaceutical Market" - Leading Domestic Companies 2015’ is released today.
Dublin, Ireland, September 19, 2015 --(PR.com)-- This report discusses the Indian pharmaceutical industry in depth, with specific focus on the ten leading domestic India pharmaceutical companies; their key financials since FY2011; their key global markets; their Merger, Acquisition and Joint Venture activity; their Research & Development spending; as well as Strength, Weakness, Opportunity and Threats that each individual company faces. This report also offers a snapshot of the key financials in the India pharmaceutical sector; import / export values, and where the India based pharmaceutical companies are generating their revenue globally. The report concludes with interviews with directors of Ipca Laboratories, Cadila Healthcare and Cipla.
The Indian Pharmaceutical Market - Leading Domestic Companies 2015 also highlights what drives, or restrains, the market for these leading companies;
Key Drivers:
US Generics Market
JV, Acquisitions & Mergers
Patent Cliff
Increased Domestic Health Spending
Geographic Expansion into Semi-Regulated and Emerging Pharma Markets
Economies in Drug Production/Manufacture
Governmental Support
Key Restraints
Industry Inefficiencies
Regulatory Non-Compliance
Price Ceilings
Intellectual Property Rights / Compulsory Licence
Inadequate Health Insurance, India
The US generics market has been a massive growth driver for the India pharmaceutical market, with many leading companies in GMR Data’s list generating over 50% of their annual revenues from the US generics market. However with access to the US market comes increased scrutiny from the US FDA; nearly all the companies in the top ten have faced warnings from the FDA; ranging from minor procedural infractions to complete manufacturing shutdown.
The report contains over 130 tables & figures across 152 pages and concludes with 3 exclusive interviews with managing directors of 3 leading Indian pharmaceutical companies;
· Cipla
· Cadila Healthcare
· IPCA Laboratories
To order this report please contact Alice Morgan on TEL: +353 86 075 2687 or by emailing Alice.Morgan@GMRData.com
The Indian Pharmaceutical Market - Leading Domestic Companies 2015 also highlights what drives, or restrains, the market for these leading companies;
Key Drivers:
US Generics Market
JV, Acquisitions & Mergers
Patent Cliff
Increased Domestic Health Spending
Geographic Expansion into Semi-Regulated and Emerging Pharma Markets
Economies in Drug Production/Manufacture
Governmental Support
Key Restraints
Industry Inefficiencies
Regulatory Non-Compliance
Price Ceilings
Intellectual Property Rights / Compulsory Licence
Inadequate Health Insurance, India
The US generics market has been a massive growth driver for the India pharmaceutical market, with many leading companies in GMR Data’s list generating over 50% of their annual revenues from the US generics market. However with access to the US market comes increased scrutiny from the US FDA; nearly all the companies in the top ten have faced warnings from the FDA; ranging from minor procedural infractions to complete manufacturing shutdown.
The report contains over 130 tables & figures across 152 pages and concludes with 3 exclusive interviews with managing directors of 3 leading Indian pharmaceutical companies;
· Cipla
· Cadila Healthcare
· IPCA Laboratories
To order this report please contact Alice Morgan on TEL: +353 86 075 2687 or by emailing Alice.Morgan@GMRData.com
Contact
GMR Data
Alice Morgan
+353 86 075 2687
http://gmrdata.com/
Alice Morgan
+353 86 075 2687
http://gmrdata.com/
Contact
Categories